ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine
Sponsors
Roswell Park Cancer Institute
Conditions
Recurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity CancerStage IA Fallopian Tube CancerStage IA Ovarian Epithelial CancerStage IA Primary Peritoneal Cavity CancerStage IB Fallopian Tube CancerStage IB Ovarian Epithelial Cancer
Phase 1
Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
CompletedNCT01536054
Start: 2012-08-20End: 2015-04-21Updated: 2020-03-27
Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission
WithdrawnNCT01982487
Start: 2013-12-31Updated: 2013-12-18